The pioneers | Spectrum California became the first U.S. state to legalize medical marijuana, mainly for adults with severe chronic illness such as cancer or AIDS. Since California’s decision in 1996, 24 states and the District of Columbia (Washington, D.C.) have followed, and since 2012, four states and Washington, D.C., have legalized recreational use of the drug. So far, only Pennsylvania specifically permits medical marijuana use for autism, but in the past few years, parents of children with epilepsy across the nation have adopted this approach. Much of this enthusiasm stemmed from the widespread media coverage in 2013 of Charlotte’s Web, a marijuana strain with high levels of CBD. Around that time, Karlee was at her wits’ end. Giving her son marijuana was not an easy decision for Karlee. With her prescription in hand, Karlee was able to visit a for-profit medical dispensary that sells marijuana oils and tinctures — marijuana extracts steeped in alcohol.
Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative - Research & Training NIH Home > Research & Training What is the BRAIN Initiative? The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is part of a new Presidential focus aimed at revolutionizing our understanding of the human brain. A map of overall task-fMRI brain coverage from the seven tasks used in the Human Connectome Project. THE BRAIN INITIATIVE and BRAIN RESEARCH THROUGH ADVANCING INNOVATIVE NEUROTECHNOLOGIES are service marks of the U.S. Meeting Information May 29, 2013, San Francisco, CA Focus: Molecular approaches View the Agenda June 26, 2013, New York, NY Focus: Large-scale recording technologies View the Agenda July 29, 2013, Boston, MA Focus: Computation, theory, and big data View the Agenda August 29, 2013, Minneapolis, MN Focus: Human Neuroscience View the Agenda This page last reviewed on April 9, 2014
Role for Fatty Acid Metabolism in Preclinical AD? Action Points Note that this observational study found an association between higher levels of docosahexaenoic acid and lower levels of cerebral amyloidosis.Be aware that the study was focused on individuals with significant vascular risk factors and may not be generalizable to the population at large. Limited seafood intake may increase the risk of brain amyloid deposition and Alzheimer's disease (AD), according to new research. Greater levels of the essential fatty acid docosahexaenoic (DHA) were associated with less cerebral amyloidosis, larger brain volumes, and better cognitive measures in cognitively healthy patients, Hussein N. In 61 older participants enrolled in the Aging Brain Study, serum DHA levels (the percentage of total fatty acids) were 23% lower in those with significantly more cerebral amyloidosis than in those without (0.97 versus 1.25). In an accompanying editorial, Joseph F. So what's a clinician to do? Reviewed by F.
Human Connectome Project The New Drug That Could Treat Alzheimer's - Introducing NTRX-07 In Brief Five million people, in the US alone, could be significantly helped by a new drug to treat Alzheimer's Disease. There have been many recent breakthroughs in the study and treatment of nuerodegenerative disorders. From medication to gene therapy, new solutions are continually popping up to instill greater hope. Targeting Inflammation New developments and research into treating Alzheimer’s disease are always welcome. “This drug may reduce inflammation in the brain, which is linked to Alzheimer’s disease,” says lead researcher Mohamed Naguib of Cleveland Clinic. “NTRX-07 uses a different mechanism than many other Alzheimer’s drugs currently available, as it targets the cause of the disease, not just the symptoms,” Naguib explains. Restoring Memory and Lives During tests on mice bred to show neurodegenerative issues similar to Alzheimer’s, NTRX-07 showed memory-restoring abilities.
Mis Recetas Anticáncer Sugar Harms Your Brain Health, Drives Alzheimer’s Epidemic By Dr. Joseph Mercola Guest Writer for Wake Up World Alzheimer’s disease, a severe form of dementia, affects an estimated 5.2 million Americans, according to 2013 statistics. One in nine seniors over the age of 65 has Alzheimer’s, and the disease is now thought to be the third leading cause of death in the US, right behind heart disease and cancer. A growing body of research suggests there’s a powerful connection between your diet and your risk of developing Alzheimer’s disease, via similar pathways that cause type 2 diabetes. Contrary to popular belief, your brain does not require glucose, and actually functions better burning alternative fuels, especially ketones, which your body makes in response to digesting healthy fats. According to some experts, such as Dr. Sugar Damages Brain Structure and Function In your brain, insulin helps with neuron glucose-uptake and the regulation of neurotransmitters, such as acetylcholine, which are crucial for memory and learning. Neurologist Dr.
Who's My Doctor? The Total Transparency Manifesto 'Mental Flossing' May Cut Cognitive Risk in Elderly Action Points Engaging in mentally stimulating activities even in late life may be protective against new-onset mild cognitive impairment (MCI), according to a prospective observational study.Note that the associations of mentally stimulating activities with risk of MCI may vary according to carrier status of APOE ε4, a genotype that is a well-known risk factor for MCI and Alzheimer Disease. Mentally stimulating activities may diminish the risk of mild cognitive impairment (MCI) in older people -- even in apolipoprotein E ε4 (APOE4) carriers, researchers found. In the population-based Mayo Clinic Study of Aging, several activities -- playing games, doing crafts, using the computer, and socializing -- were each associated with a significantly decreased risk of MCI in cognitively normal people age 70 and up over a median follow-up of 4 years, Yonas Geda, MD, of the Mayo Clinic in Scottsdale, Ariz., and colleagues reported online in JAMA Neurology. Reviewed by Henry A.
Home - SolveBio Study: Opioid Abuse Rates Lower In Medical Marijuana States By Paul Armentano, NORML Deputy Director Rates of prescription opioid abuse are significantly lower in jurisdictions that permit medical marijuana access, according to data reported by Castlight Health, an employee health benefits platform provider. Investigators assessed anonymous prescription reporting data from over one million employees between the years 2011 and 2015. In states that did not permit medical marijuana access, 5.4 percent of individuals with an opioid prescription qualified as abusers of the drug. The findings are similar to those reported by the RAND Corporation in 2015, which determined, “[S]tates permitting medical marijuana dispensaries experience a relative decrease in both opioid addictions and opioid overdose deaths compared to states that do not.” Full text of the new study, “The opioid crisis in America’s workforce,” appears online here. Source: NORML - make a donation
fundación contra la hipertensión pulmonar This Is Your Brain on Drugs The gray matter of the nucleus accumbens, the walnut-shaped pleasure center of the brain, was glowing like a flame, showing a notable increase in density. “It could mean that there’s some sort of drug learning taking place,” speculated Jodi Gilman, at her computer screen at the - Center for Addiction Medicine. Was the brain adapting to marijuana exposure, rewiring the reward system to demand the drug? Dr. Moderate marijuana use by healthy adults seems to pose little risk, and there are potential medical benefits, including easing nausea and pain. Photo Marijuana samples seized by the federal Drug Enforcement Agency show the concentration of THC, the drug’s psychoactive compound, rising from a mean of 3.75 percent in 1995 to 13 percent in 2013. High-THC marijuana is associated with paranoia and , according to a June article in The New England Journal of Medicine. Higher potency may also accelerate addiction. The study was preliminary and small, and attempts to replicate it are underway.